id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id FDA-1975-N-0013-0042,FDA,FDA-1975-N-0013,FDA to Buchanan Ingersoll & Rooney PC - Petition Denial,Other,PDN-Petition Denial,2010-04-08T04:00:00Z,2010,4,2010-04-08T04:00:00Z,,2013-08-11T01:33:43Z,,0,0,0900006480ad362d FDA-1975-N-0013-0035,FDA,FDA-1975-N-0013,"Tab J - ""Alcavis International, Inc. Letter to FDA, February 10, 2004"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC) - Request for Hearing] re FDA-1975-N-0013-0025",Supporting & Related Material,HER-Request for Hearing (Supporting and Related Material),2009-12-16T05:00:00Z,2009,12,,,2009-12-22T20:21:02Z,,0,0,0900006480a4e3f4 FDA-1975-N-0013-0025,FDA,FDA-1975-N-0013,"Request for Hearing from Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)",Other,Request for Hearing,2009-12-16T05:00:00Z,2009,12,2009-12-16T05:00:00Z,,2017-11-13T19:00:29Z,,0,0,0900006480a4e166 FDA-1975-N-0013-0031,FDA,FDA-1975-N-0013,"Tab F - ""68 Federal Register 3203 Dated May 29, 2003"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC) - Request for Hearing] re FDA-1975-N-0013-0025",Supporting & Related Material,HER-Request for Hearing (Supporting and Related Material),2009-12-16T05:00:00Z,2009,12,,,2009-12-22T20:19:17Z,,0,0,0900006480a4e3ef FDA-1975-N-0013-0032,FDA,FDA-1975-N-0013,"Tab G - ""Alcavis International, Inc. Letter to FDA, June 5 2003"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC) - Request for Hearing] re FDA-1975-N-0013-0025",Supporting & Related Material,HER-Request for Hearing (Supporting and Related Material),2009-12-16T05:00:00Z,2009,12,,,2009-12-22T20:19:43Z,,0,0,0900006480a4e3f0 FDA-1975-N-0013-0036,FDA,FDA-1975-N-0013,"Tab K - ""Alcavis International, Inc. Letter to FDA, March 15, 2004"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC) - Request for Hearing] re FDA-1975-N-0013-0025",Supporting & Related Material,HER-Request for Hearing (Supporting and Related Material),2009-12-16T05:00:00Z,2009,12,,,2009-12-22T20:21:59Z,,0,0,0900006480a4e6e4 FDA-1975-N-0013-0037,FDA,FDA-1975-N-0013,"Tab L - ""Alcavis International, Inc. (Alston & Bird, LLP) Letter to FDA, July 15, 2005"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC) - Request for Hearing] re FDA-1975-N-0013-0025",Supporting & Related Material,HER-Request for Hearing (Supporting and Related Material),2009-12-16T05:00:00Z,2009,12,,,2009-12-22T20:22:19Z,,0,0,0900006480a4e6e5 FDA-1975-N-0013-0041,FDA,FDA-1975-N-0013,"Index of Select Scientific References Cited - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC) - Request for Hearing] re FDA-1975-N-0013-0025",Supporting & Related Material,HER-Request for Hearing (Supporting and Related Material),2009-12-16T05:00:00Z,2009,12,,,2009-12-16T23:44:27Z,,0,0,0900006480a4e6ea FDA-1975-N-0013-0034,FDA,FDA-1975-N-0013,"Tab I - ""Alcavis International, Inc. Letter to FDA, July 1, 2003"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC) - Request for Hearing] re FDA-1975-N-0013-0025",Supporting & Related Material,HER-Request for Hearing (Supporting and Related Material),2009-12-16T05:00:00Z,2009,12,,,2009-12-22T20:20:36Z,,0,0,0900006480a4e3f2 FDA-1975-N-0013-0040,FDA,FDA-1975-N-0013,"Tab O - ""FDA/CDER Response to Alcavis International, Inc. - Petition Denial, April 24, 2009"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC) - Request for Hearing] re FDA-1975-N-0013-0025",Supporting & Related Material,HER-Request for Hearing (Supporting and Related Material),2009-12-16T05:00:00Z,2009,12,,,2009-12-22T20:24:07Z,,0,0,0900006480a4e6e8 FDA-1975-N-0013-0024,FDA,FDA-1975-N-0013,"Citizen Petition from Amuchina International, Inc.",Other,Citizen Petition,2009-12-16T05:00:00Z,2009,12,2009-12-16T05:00:00Z,,2017-11-16T14:57:17Z,,0,0,09000064805c1daa FDA-1975-N-0013-0027,FDA,FDA-1975-N-0013,"Tab B - ""Citizen Petition Filed by Alcavis, International, Inc., February 20, 2002"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC) - Request for Hearing] re FDA-1975-N-0013-0025",Supporting & Related Material,HER-Request for Hearing (Supporting and Related Material),2009-12-16T05:00:00Z,2009,12,,,2009-12-22T20:17:20Z,,0,0,0900006480a4e1b5 FDA-1975-N-0013-0028,FDA,FDA-1975-N-0013,"Tab C - ""FDA Response to Alcavis International, Inc., November 14, 2002"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC) - Request for Hearing] re FDA-1975-N-0013-0025",Supporting & Related Material,HER-Request for Hearing (Supporting and Related Material),2009-12-16T05:00:00Z,2009,12,,,2009-12-22T20:17:51Z,,0,0,0900006480a4e1d2 FDA-1975-N-0013-0029,FDA,FDA-1975-N-0013,"Tab D - ""Alcavis International, Inc. Letter to FDA, December 20, 2002"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC) - Request for Hearing] re FDA-1975-N-0013-0025",Supporting & Related Material,HER-Request for Hearing (Supporting and Related Material),2009-12-16T05:00:00Z,2009,12,,,2009-12-22T20:18:18Z,,0,0,0900006480a4e1e9 FDA-1975-N-0013-0033,FDA,FDA-1975-N-0013,"Tab H - ""Alcavis International, Inc. Letter to FDA, June 17, 2003"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC) - Request for Hearing] re FDA-1975-N-0013-0025",Supporting & Related Material,HER-Request for Hearing (Supporting and Related Material),2009-12-16T05:00:00Z,2009,12,,,2009-12-22T20:20:08Z,,0,0,0900006480a4e3f1 FDA-1975-N-0013-0043,FDA,FDA-1975-N-0013,"Tabs 1 through 12 - ""Select Scientific References Cited"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC) - Request for Hearing] re FDA-1975-N-0013-0025",Supporting & Related Material,Background Material,2009-12-16T05:00:00Z,2009,12,,,2017-11-16T20:06:03Z,,0,0,0900006480a4e7e1 FDA-1975-N-0013-0030,FDA,FDA-1975-N-0013,"Tab E - ""Alcavis International, Inc. Letter to FDA, March 18, 2003"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC) - Request for Hearing] re FDA-1975-N-0013-0025",Supporting & Related Material,HER-Request for Hearing (Supporting and Related Material),2009-12-16T05:00:00Z,2009,12,,,2009-12-22T20:18:40Z,,0,0,0900006480a4e3ee FDA-1975-N-0013-0039,FDA,FDA-1975-N-0013,"Tab N - ""Alcavis International, Inc. (Alston & Bird, LLP) Supplement, February 6, 2009"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC) - Request for Hearing] re FDA-1975-N-0013-0025",Supporting & Related Material,HER-Request for Hearing (Supporting and Related Material),2009-12-16T05:00:00Z,2009,12,,,2009-12-22T20:23:37Z,,0,0,0900006480a4e6e7 FDA-1975-N-0013-0038,FDA,FDA-1975-N-0013,"Tab M - ""Alcavis International, Inc. (Alston & Bird, LLP) Letter to FDA, October 4, 2006"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC) - Request for Hearing] re FDA-1975-N-0013-0025",Supporting & Related Material,HER-Request for Hearing (Supporting and Related Material),2009-12-16T05:00:00Z,2009,12,,,2009-12-22T20:22:58Z,,0,0,0900006480a4e6e6 FDA-1975-N-0013-0026,FDA,FDA-1975-N-0013,"Tab A - ""Citizen Petition Filed by Amuchina, International, Inc. (Atkin, Gump, Strauss, Hauer & Feld), January 29, 1999 - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC) - Request for Hearing] re FDA-1975-N-0013-0025",Supporting & Related Material,HER-Request for Hearing (Supporting and Related Material),2009-12-16T05:00:00Z,2009,12,,,2009-12-22T20:16:53Z,,0,0,0900006480a4e16c FDA-1975-N-0013-0023,FDA,FDA-1975-N-0013,"Petition Denial from FDA/CDER to Alcavis International, Inc.",Other,Denial of Petition,2009-04-24T04:00:00Z,2009,4,2009-04-24T04:00:00Z,,2017-11-02T18:36:20Z,,0,0,0900006480969491 FDA-1975-N-0013-0022,FDA,FDA-1975-N-0013,Letter from Alcavis International Inc. to FDA,Other,Letter(s),2009-03-04T05:00:00Z,2009,3,2009-03-04T05:00:00Z,,2017-10-05T19:35:24Z,,0,0,09000064808eaa2a FDA-1975-N-0013-0021,FDA,FDA-1975-N-0013,Letter from Alcavis International Inc. to FDA,Other,Letter(s),2009-03-04T05:00:00Z,2009,3,2009-03-04T05:00:00Z,,2017-10-05T19:36:58Z,,0,0,09000064808ea462 FDA-1975-N-0013-0020,FDA,FDA-1975-N-0013,"Alcavis HDC, LLC (Alston & Bird, LLP) - Supplement Petition [re CP4]",Other,SUP-Supplement,2009-02-10T05:00:00Z,2009,2,2009-02-10T05:00:00Z,,2013-07-27T22:37:51Z,,0,0,090000648084a33f FDA-1975-N-0013-0015,FDA,FDA-1975-N-0013,Topical Antimicrobial Drug Products for Over-the-Counter Human Use; Tentative Final Monograph for First Aid Antiseptic Drug Products,Notice,Correction,2009-01-13T05:00:00Z,2009,1,2009-01-13T05:00:00Z,1992-01-22T04:59:59Z,2017-11-02T15:03:55Z,,0,0,09000064805c1d4d FDA-1975-N-0013-0005,FDA,FDA-1975-N-0013,Topical Antimicrobial Drug Products for Over-the-Counter Human Use; Tentative Final Monograph for First Aid Antiseptic Drug Products,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2009-01-12T05:00:00Z,2009,1,2009-01-12T05:00:00Z,1992-01-22T04:59:59Z,2017-10-03T17:08:32Z,FR Doc. 91-17107,0,0,09000064805c1d3d FDA-1975-N-0013-0004,FDA,FDA-1975-N-0013,"Acknowledgement Letter from FDA/DDM to Century Pharmaceuticals, Inc.",Other,Acknowledgement Letter/Receipt,2007-04-10T04:00:00Z,2007,4,,,2017-11-16T14:18:21Z,,0,0,09000064805c1dca FDA-1975-N-0013-0001,FDA,FDA-1975-N-0013,Status of Certain Additional Over-the-Counter Drug Category II and III Active Ingredients,Notice,Notice of Final Rule,1998-04-22T04:00:00Z,1998,4,,,2017-11-16T02:02:43Z,98–10578,0,0,09000064805c1d3c